The ARKG ETF Doesn’t Need More Catalysts. It’s Getting Them Anyway
December 15, 2020 at 11:45 AM EST
The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) doesn’t need more catalysts, but in the rapidly evolving genomics spaces they keep on coming. ARKG is a substantial departure from the health care ETF most investors are accustomed to. That’s not a bad thing. “Securities within...